Company: BACC
Filing Date: 2025-03-26
Form Type: DRS
Source: 0001185185-25-000217
Chunk: 145

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-03-26
Form: DRS
Chunk 145
---
 |     |                |  (4,312,500 | ) |     |                           |  (7,500,000 | ) |     |                |  (8,625,000 | ) |     |                           |  (11,250,000 | ) |     |                |  (12,937,500 | ) |     |                            |  (15,000,000 | ) |     |                |  (17,250,000 | ) |
| Total                                                                            |     |                           |  18,791,000 |   |     |                |  21,555,800 |   |     |                           |  15,041,000 |   |     |                |  17,243,300 |   |     |                           |  (11,291,000 | ) |     |                |   12,930,800 |   |     |                            |    7,541,000 |   |     |                |    8,618,300 |   |

| (1) | Expenses applied against gross proceeds include offering expenses of                                                                 
 approximately $750,000 and underwriting commissions of $0.20 per unit (including any units sold pursuant to the underwriters’ option 
 to purchase additional units), or $3,000,000 in the aggregate (or $3,450,000 if the underwriters’ over-allotment option is exercised 
 in full), payable to BTIG and Roberts & Ryan (excluding deferred underwriting commissions). See “Use of Proceeds.”                   |

| (2) | Upon the consummation of our initial business combination, the deferred                                                                 
 underwriting commissions would be paid as follows: $0.40 per unit on all units sold including those sold pursuant to the underwriters’  
 option to purchase additional units, or $6,000,000 in the aggregate (or $6,900,000 in the aggregate if the underwriters’ over-allotment 
 option is exercised in full) payable to BTIG and Roberts & Ryan for deferred underwriting commissions. See also “Underwriting”          
 for a description of compensation and other items of value payable to the underwriters.                                                 |

| (3) | If                                                                                                                                         
 we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business 
 combination pursuant to the tender offer rules, our sponsor, initial shareholders, directors, executive officers or their affiliates       
 may purchase shares or